Lack of tracking of medical devices' performance raises questions about safety and efficacy

NewsGuard 100/100 Score
"Amid the booming use of artificial joints in the United States, the breakup between Dr. Berger and Zimmer highlights what experts say is a troubling situation for patients and doctors: when disputes arise about orthopedic implant safety, there are no independent referees or sources of information because no one tracks the performance of the devices. ... While producers of implanted heart devices have a voluntary system in which outside panels investigate problems, American makers of orthopedic devices do not. Many of the artificial joints that surgeons like Dr. Berger use, including the Zimmer knee at issue, are cleared under law by the Food and Drug Administration for sale without testing in patients" (Meier, 6/18).

Meanwhile, The Wall Street Journal reports on Paro, a Japanese robotic seal pup used to "lift the spirits of millions of elderly adults." The device "never quite caught on" in Japan but is now coming to the U.S. with some controversy. "Nursing-home workers and academics who study human-robot interaction are trying to figure out whether the $6,000 seal, cleared last fall by U.S. regulators as a Class 2 medical device (a category that includes powered wheelchairs) represents a disturbing turn in our treatment of the elderly or the best caregiving gadget since the Clapper."

Bill Thomas, "founder of the Green House Project, a campaign to make nursing homes smaller and more like regular houses," believes "it's inhumane to entrust the task of emotional support to a gadget." But "In several countries, robots are starting to play a role in elder care. In Japan—where 22.3% of the population is over 65—robots handle such tasks as feeding patients and helping disabled people move their limbs. Also planned are wheelchairs with robot arms and robotic diet-and-exercise coaches." Paro, however, "isn't a mechanical aid. It serves as a low-maintenance alternative to the cats and dogs many nursing homes import for 'pet therapy' visits" (Tergesen and Inada, 6/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 vaccines show moderate success in preventing long COVID in kids